Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA.
Heart Rhythm. 2013 May;10(5):720-5. doi: 10.1016/j.hrthm.2013.01.032. Epub 2013 Jan 29.
Individual corrected QT interval (QTc) may vary widely among carriers of the same long QT syndrome (LQTS) mutation. Currently, neither the mechanism nor the implications of this variable penetrance are well understood.
To hypothesize that the assessment of QTc variance in patients with congenital LQTS who carry the same mutation provides incremental prognostic information on the patient-specific QTc.
The study population comprised 1206 patients with LQTS with 95 different mutations and ≥ 5 individuals who carry the same mutation. Multivariate Cox proportional hazards regression analysis was used to assess the effect of mutation-specific standard deviation of QTc (QTcSD) on the risk of cardiac events (comprising syncope, aborted cardiac arrest, and sudden cardiac death) from birth through age 40 years in the total population and by genotype.
Assessment of mutation-specific QTcSD showed large differences among carriers of the same mutations (median QTcSD 45 ms). Multivariate analysis showed that each 20 ms increment in QTcSD was associated with a significant 33% (P = .002) increase in the risk of cardiac events after adjustment for the patient-specific QTc duration and the family effect on QTc. The risk associated with QTcSD was pronounced among patients with long QT syndrome type 1 (hazard ratio 1.55 per 20 ms increment; P<.001), whereas among patients with long QT syndrome type 2, the risk associated with QTcSD was not statistically significant (hazard ratio 0.99; P = .95; P value for QTcSD-by-genotype interaction = .002).
Our findings suggest that mutations with a wider variation in QTc duration are associated with increased risk of cardiac events. These findings appear to be genotype-specific, with a pronounced effect among patients with the long QT syndrome type 1 genotype.
在携带相同长 QT 综合征 (LQTS) 突变的个体中,个体校正 QT 间期 (QTc) 可能差异很大。目前,这种可变外显率的机制和影响都还没有被很好地理解。
假设在携带相同突变的先天性 LQTS 患者中评估 QTc 变异性,可提供关于患者特定 QTc 的额外预后信息。
研究人群包括 1206 名 LQTS 患者,携带 95 种不同的突变,且每种突变至少有 5 名携带者。多变量 Cox 比例风险回归分析用于评估突变特异性 QTc 标准差 (QTcSD) 对总人群和基因型患者从出生到 40 岁时心脏事件(包括晕厥、心搏骤停和心源性猝死)风险的影响。
评估突变特异性 QTcSD 显示,相同突变携带者之间存在很大差异(中位数 QTcSD 为 45ms)。多变量分析显示,校正患者特定 QTc 持续时间和 QTc 对家族的影响后,QTcSD 每增加 20ms,心脏事件的风险显著增加 33%(P=0.002)。在 1 型长 QT 综合征患者中,与 QTcSD 相关的风险较大(每增加 20ms,风险比为 1.55;P<0.001),而在 2 型长 QT 综合征患者中,与 QTcSD 相关的风险无统计学意义(风险比为 0.99;P=0.95;QTcSD-基因型交互作用 P 值为 0.002)。
我们的研究结果表明,QTc 持续时间变化较大的突变与心脏事件风险增加相关。这些发现似乎是基因型特异性的,在 1 型长 QT 综合征基因型患者中影响更为显著。